Taken together, these data suggest that increased mTORC1 activity in SLE CD4+ T cells might mediate upregulation of EZH2 through increasing glycolysis and the resulting suppression of miR-26a and miR-101. Here, EZH2 is linked to systemic lupus erythematosus.